157 related articles for article (PubMed ID: 38376154)
1. Investigating the impact of antibiotic-induced dysbiosis on protection from
Uddin MJ; Thompson B; Leslie JL; Fishman C; Sol-Church K; Kumar P; Petri WA
mBio; 2024 Mar; 15(3):e0333823. PubMed ID: 38376154
[TBL] [Abstract][Full Text] [Related]
2. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
Frisbee AL; Saleh MM; Young MK; Leslie JL; Simpson ME; Abhyankar MM; Cowardin CA; Ma JZ; Pramoonjago P; Turner SD; Liou AP; Buonomo EL; Petri WA
Nat Commun; 2019 Jun; 10(1):2712. PubMed ID: 31221971
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen augments susceptibility to
Fachi JL; Pral LP; Assis HC; Oliveira S; Rodovalho VR; Dos Santos JAC; Fernandes MF; Matheus VA; Sesti-Costa R; Basso PJ; Flóro E Silva M; Câmara NOS; Giorgio S; Colonna M; Vinolo MAR
Gut Microbes; 2024; 16(1):2297872. PubMed ID: 38165200
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.
Abt MC; Lewis BB; Caballero S; Xiong H; Carter RA; Sušac B; Ling L; Leiner I; Pamer EG
Cell Host Microbe; 2015 Jul; 18(1):27-37. PubMed ID: 26159718
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
7. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
8. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
[TBL] [Abstract][Full Text] [Related]
9. Correlating Antibiotic-Induced Dysbiosis to
Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
11. The microbiota and immune response during Clostridium difficile infection.
Buonomo EL; Petri WA
Anaerobe; 2016 Oct; 41():79-84. PubMed ID: 27212111
[TBL] [Abstract][Full Text] [Related]
12. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.
Cribas ES; Denny JE; Maslanka JR; Abt MC
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA-seq identifies a PD-1
Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P
Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818
[TBL] [Abstract][Full Text] [Related]
14. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
Jeffery HC; McDowell P; Lutz P; Wawman RE; Roberts S; Bagnall C; Birtwistle J; Adams DH; Oo YH
PLoS One; 2017; 12(12):e0188649. PubMed ID: 29261670
[TBL] [Abstract][Full Text] [Related]
15. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.
Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP
Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
[No Abstract] [Full Text] [Related]
17. Outbreak of Murine Infection with
Mau T; Eckley SS; Bergin IL; Saund K; Villano JS; Vendrov KC; Snitkin ES; Young VB; Yung R
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894434
[TBL] [Abstract][Full Text] [Related]
18. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions.
Monticelli LA; Osborne LC; Noti M; Tran SV; Zaiss DM; Artis D
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10762-7. PubMed ID: 26243875
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
20. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM
JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
